Maze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...

Apolipoprotein E4 (apoE4) and female sex are risk factors for developing Alzheimer's disease. It is unclear whether apoE4 contributes to behavioral function at younger ages. Standard ...

View all available purchase options and get full access to this article.

Apolipoprotein A-I mimetic peptides are amphipathic alpha-helix peptides that display similar functions to apolipoprotein A-I. Preclinical and clinical studies have demonstrated the safety and ...

Apolipoprotein E (ApoE) is a key genetic risk factor in the complex landscape of Alzheimer’s disease (AD), especially in its late-onset sporadic form. Genetic variation in the ApoE gene is a ...

High cholesterol levels can pose significant risks to health, including affecting memory. Research highlights a link between ...

The study, published in Food Frontiers, concluded that plant-based meat alternatives are likely to be safe when part of a ...

She corrects the widespread misconception, claiming that eradicating fat to reduce cholesterol is "nonsense." Contrary to ...

Gum disease, or periodontitis, has been linked to poorer cognitive function. Researchers believe this connection may be due ...

Maze Therapeutics Inc. has divulged apolipoprotein L1 (APOL1) inhibitors reported to be useful for the treatment of chronic kidney disease, focal segmental glomerulosclerosis, diabetic retinopathy, ...

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.